This Quarterly Report on Form 10-Q contains forward-looking statements. All
statements contained in this Quarterly Report on Form 10-Q other than statements
of historical fact, including statements regarding our future operating results
and financial position, our business strategy and plans, market growth, trends,
events, and our objectives for future operations, are forward-looking
statements. The words "may," "will," "expect," "anticipate," "believe,"
"intend," "project," "could," "would," "estimate," "potential," "continue,"
"plan," "target," or the negative of these words or similar expressions are
intended to identify forward-looking statements.



The forward-looking statements included herein are based on current expectations
of management. Actual results may differ from those expressed in forward-looking
statements due to additional factors, including those set forth in Item 1A.
"Risk Factors" elsewhere in this Quarterly Report on Form 10-Q. Although we
believe that expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, performance, or achievements.
The events and circumstances reflected in our forward-looking statements may not
be achieved or occur, and actual results could differ materially from those
projected in the forward-looking statements. Moreover, we operate in an evolving
environment. New risk factors and uncertainties may emerge from time to time,
and it is not possible for management to predict all risk factors and
uncertainties. As a result of these factors, we cannot assure you that the
forward-looking statements in this Quarterly Report on Form 10-Q will prove to
be accurate. Except as required by applicable law, we do not plan to publicly
update or revise any forward-looking statements contained herein, whether as a
result of any new information, future events, changed circumstances, or
otherwise.



You should read this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.





Business Overview

Desktop Metal is pioneering a new generation of additive manufacturing
technologies focused on the production of end-use parts. We offer a
comprehensive portfolio of integrated additive manufacturing solutions
comprising hardware, software, materials and services with support for metals,
composites, polymers, ceramics, sands, and biocompatible materials. Our
solutions span use cases across the product life cycle, from product development
to mass production and aftermarket operations, and they address an array of
industries, including automotive, aerospace, healthcare and dental, consumer
products, heavy industry, general machinery and machine components and research
and development.

Our growth strategy begins with a commitment to research and development. Since
our founding in 2015, we have invested significant resources in research and
development, including $10.9 million thus far in 2021, towards building an
extensive portfolio of proprietary and differentiated technologies with a focus
on making additive manufacturing an easy-to-use, economic and scalable solution.
These technologies represent the cornerstones of our future product
introductions and are critical to enhancing our existing offerings, and we have
over 300 registered patents or pending patent applications. Our additive
manufacturing platforms, which leverage these technologies for the production of
end-use parts, enable businesses to address their specific goals through a range
of solutions that span multiple price points, throughput levels and operating
environments.

These platforms enable customers to adopt additive manufacturing across new
applications where conventional manufacturing has customarily held cost and
volume advantages by offering breakthrough print speeds, competitive part costs,
accessible workflows and software, turnkey solutions, and support for over 225
qualified materials, the sale of which represent a recurring revenue stream from
customers of our additive manufacturing systems in addition to system
consumables and other services, such as installation, training and technical
support. Across printers, parts and materials, we intend to continue investing
resources to develop advances and new technologies that allow us to serve a
broader customer base and reach new verticals, thereby expanding our addressable
market and driving adoption of additive manufacturing for the volume production
of end-use parts.

We leverage our core competencies in technology innovation and product
development by marketing and selling our additive manufacturing solutions
through a leading global distribution network, managed and augmented by our own
internal sales and marketing teams. This distribution network covers over 60
countries around the world and is composed of sales professionals with decades
of experience in digital manufacturing technologies. Similarly, in addition to
manufacturing a subset of our additive manufacturing systems in-house, our
internal manufacturing and supply chain teams work collaboratively with both our
internal engineering department and third-party contract manufacturers to scale
up initial prototypes for commercialization and volume

                                       31

Table of Contents

commercial shipments. Together, our distribution network and manufacturing approach allow us to produce, sell and service our products at-scale in global markets and creates substantial operating leverage as we execute our strategy.

Operating Results


For the three months ended March 31, 2021, we recognized revenues of $11.3
million and used cash in operating activities of $41.1 million, and we ended the
period with $572.2 million of cash, cash equivalents, and short-term
investments. We incurred a net loss of $59.1 million for the three months ended
March 31, 2021. In December 2020, we completed the Business Combination,
receiving $534.6 million net cash proceeds, and during the first three months of
2021, the public warrants were exercised, generating $170.7 million of net cash
proceeds, both of which we expect to support our operations and investments in
the near term. As of March 31, 2021, we had $416.4 million in cash and cash
equivalents, $155.8 million in short-term liquid investments, and current
liabilities of $37.5 million.

Recent Developments

EnvisionTEC Acquisition


On February 16, 2021, pursuant to the Purchase Agreement and Plan of Merger
dated January 14, 2021, we consummated the EnvisionTEC Acquisition. We paid
$143.8 million in cash and issued 5,036,142 Class A common shares with a fair
value of $159.8 million as of the close of business on the acquisition date. In
connection with the transaction, the Company also agreed to grant restricted
stock awards totaling 475,848 shares of the Company's Common Stock to key
EnvisionTEC employees. As of March 31, 2021, the Company has not completed the
grant of restricted stock awards.

Desktop Health



On March 15, 2021, we announced the launch of Desktop Health, a new business
focused on accelerating the growth of additive manufacturing solutions for
dental, orthodontic, otolaryngology and dermatology applications. Enabled by
Desktop Metal's proprietary technology infrastructure for end-use parts
production, including high-speed photopolymer, metal binder jetting and
bioprinting additive manufacturing technologies combined with an extensive
library of advanced materials, Desktop Health's mission is to create advanced,
patient-specific solutions in the medical field.

Trine Warrants



On April 12, 2021, the Staff of the SEC issued the "Staff Statement on
Accounting and Reporting Considerations for Warrants Issued by Special Purpose
Acquisition Companies ("SPACs")" (the "Staff Statement"). The Staff Statement
discussed "certain features of warrants issued in SPAC transactions" that "may
be common across many entities." The Staff Statement indicated that when one or
more of such features is included in a warrant, the warrant "should be
classified as a liability measured at fair value, with changes in fair value
each period reported in earnings." The Company has concluded that the Private
Placement Warrants are to be classified as a liability measured at fair value on
the Company's consolidated balance sheet upon the Business Combination on
December 9, 2020, with subsequent changes in fair value reported in our
statement of operations each reporting period. As of March 31, 2021, all Private
Placement Warrants were exercised and there was no outstanding warrant
liability.

COVID-19



In March 2020, the World Health Organization declared the outbreak of COVID-19 a
pandemic. It is not possible to accurately predict the full impact of the
COVID-19 pandemic on our business, financial condition and results of operations
due to the evolving nature of the COVID-19 pandemic and the extent of its impact
across industries and geographies and numerous other uncertainties. For example,
we face uncertainties about the duration and spread of the outbreak, additional
actions that may be taken by governmental entities, and the impact it may have
on the ability of us, our customers, our suppliers, our manufacturers and our
other business partners to conduct business. Governments in affected regions
have implemented, and may continue to implement, safety precautions which
include quarantines, travel restrictions, business closures, cancellations of
public gatherings and other measures as they deem necessary. Many organizations
and individuals, including our company and employees, are taking additional
steps to avoid or reduce infections, including limiting travel and staying home
from work. These measures are disrupting normal business operations and have had
significant negative impacts on businesses and financial markets worldwide. We
continue to monitor our operations and

                                       32

Table of Contents



government recommendations and have made modifications to our normal operations
because of the COVID-19 pandemic, including requiring most non-engineering or
operations-related team members to work remotely, utilizing heightened cleaning
and sanitization procedures, implementing new health and safety protocols and
reducing non-essential travel.

The COVID-19 pandemic has caused us to experience several adverse impacts,
including extended sales cycles to close new orders for our products, delays in
shipping and installing orders due to closed facilities and travel limitations
and delays in collecting accounts receivable. The rapid development and
uncertainty of the impacts of the COVID-19 pandemic precludes any prediction as
to the ultimate adverse impact of the COVID-19 pandemic on our business.
However, the COVID-19 pandemic, and the measures taken to contain it, present
material uncertainty and risk with respect to our performance and financial
results. In particular, businesses across an array of vertical markets are
temporarily reducing capital expenditure budgets globally as they seek to
preserve liquidity to ensure the longevity of their own operations, which in
turn may lead to reductions in purchases of our additive manufacturing
solutions. Further, office closures may prevent organizations from reaching
typical utilizations of our additive manufacturing solutions, resulting in
reductions in purchases of consumable materials. Additionally, the COVID-19
pandemic may contribute to facility closures at our third-party contract
manufacturers and key suppliers, causing delays and disruptions in product
manufacturing, which could affect our ability to ship products purchased by our
customers in a timely manner. Disruptions in the capital markets as a result of
the COVID-19 pandemic may also adversely affect our business if these impacts
continue for a prolonged period and we need additional liquidity.

In the long-term, we believe that the COVID-19 pandemic will encourage organizations to reassess their supply chain structure and may accelerate their adoption of solutions such as additive manufacturing, which could allow for greater flexibility and a reduced reliance on overseas manufacturing.

Key Factors Affecting Operating Results



We believe that our performance and future success depend on many factors that
present significant opportunities for us, but also pose risks and challenges,
including those discussed below and in "Risk Factors" section of this Quarterly
Report on Form 10-Q.

Commercial Launch of Products



Several of our products began commercial shipments in late 2020 and early 2021,
with more in the late stages of development and scheduled to begin commercial
shipments in 2021. Prior to commercialization, we must complete final testing
and manufacturing ramp-up of these products at our third-party contract
manufacturers. Any delays in successful completion of these steps may impact our
ability to generate revenue from these products.

Adoption of our Additive Manufacturing Solutions


We believe the world is at an inflection point in the adoption of additive
manufacturing solutions and that we are well-positioned to take advantage of
this opportunity across an array of industries due to our proprietary
technologies and global distribution capabilities. We expect that our results of
operations, including revenue and gross margins, will fluctuate for the
foreseeable future as businesses continue to shift away from conventional
manufacturing processes towards additive manufacturing for end-use parts. Our
turnkey and volume production solutions are designed to empower businesses to
realize the full benefits of additive manufacturing at-scale, including
geometric and design flexibility, mass customization and supply chain
engineering, among others. The degree to which potential and current customers
recognize these benefits and invest in our solutions will affect our financial
results.

Pricing, Product Cost and Margins



Our comprehensive portfolio of additive manufacturing solutions spans multiple
price points, materials, throughput levels, operating environments and
technologies to enable customers to find the solution that achieves their
specific goals. We also expect to commercialize additional previously announced
products over the course of 2021. Pricing for these products may vary by region
due to market­specific supply and demand dynamics and product lifecycles, and
sales of certain products have, or are expected to have, higher gross margins
than others. As a result, our financial performance depends, in part, on the mix
of products we sell during a given period. In addition, we are subject to price
competition, and our ability to compete in key markets will depend on the
success of our investments in new technologies and cost improvements as well as
our ability to efficiently and reliability introduce cost­effective additive
manufacturing solutions for our customers.

                                       33

Table of Contents

Continued Investment and Innovation



We believe that we are a leader in mass production and turnkey additive
manufacturing solutions, offering breakthrough technologies that enable high
throughput and ease­of­use through our broad product portfolio. Our performance
is significantly dependent on the investment we make in our research and
development efforts and on our ability to be at the forefront of the additive
manufacturing industry. It is essential that we continually identify and respond
to rapidly evolving customer requirements, develop and introduce innovative new
products, enhance existing products and generate customer demand for our
solutions. We believe that investment in our additive manufacturing solutions
will contribute to long­term revenue growth, but it may adversely affect our
near­term profitability.

Results of Operations

Comparison of the three months ended March 31, 2021 and March 31, 2020

Revenue

The following table presents the revenue of each of our revenue streams, as well as the percentage of total revenue and change from the prior year.






                                           For the Three Months Ended March 31,
                                              2021                        2020                 Change in Revenues

(Dollars in thousands)               Revenue     % of Total      Revenue   

 % of Total           $             %
Products Revenue                     $ 10,311            91 %    $  2,694            80 %    $      7,617       283 %
Services Revenue                        1,002             9 %         691            20 %             311        45 %
Total Revenue                        $ 11,313           100 %    $  3,385           100 %    $      7,928       234 %




Total revenue for the three months ended March 31, 2021 and 2020 was
$11.3 million and $3.4 million, respectively, an increase of $7.9 million, or
234%. The increase in total revenue was attributable to an increase in revenue
from both products and services.

We sold more products during the three months ended March 31, 2021 as compared
to three months ended March 31, 2020, leading to an approximately 283% increase
in product revenue. This was primarily due to product revenue from EnvisionTEC
following the close of this acquisition. Additionally, we shipped more units
during the first quarter of 2021 compared to the first quarter of 2020. For the
three months ended March 31, 2020, we experienced decreased customer demand and
longer sales cycles resulting from the COVID-19 pandemic. Additionally, as a
result of customer facilities closures associated with the COVID-19 pandemic, we
experienced delays in shipments and installation as well as decreased
utilization of our installed products, leading to a decrease in sales of
consumable materials.

Services revenue increased during the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, primarily due to an increase in support and installation revenue from increased shipments during the period.

The following table presents revenue by geographic region, as well as the percentage of total revenue and change from the prior period.






                                            For the Three Months Ended March 31,
                                                2021                      2020               Change in Revenues

(Dollars in thousands)                 Revenue     % of Total    Revenue     % of Total         $              %
Americas                               $  6,559            58 %  $  1,229            36 %  $      5,330        434 %
EMEA (Europe, the Middle East and
Africa)                                   2,741            24 %     1,851            55 %           890         48 %
APAC (Asia­Pacific)                       2,013            18 %       305             9 %         1,708        560 %
Total Revenue                          $ 11,313           100 %  $  3,385           100 %  $      7,928        234 %




Total revenue increased due to increased product sales in the Americas, EMEA and
APAC regions driven by acquisition of EnvisionTEC, diversification in our
product mix, and increased customer demand during the period ended March 31,
2021. Customer demand was lower during the three months ended March 31, 2020 as
a result of the COVID-19 pandemic.

                                       34

  Table of Contents

Cost of Sales

Total cost of sales during March 31, 2021 and 2020 was $11.9 million and $6.2
million, respectively, an increase of $5.7 million or 92%. The increase in total
cost of sales was driven primarily by an increase in product cost of sales,
which resulted from greater product sales. Additionally, costs of sales
increased $1.1 million due to amortization from intangible assets acquired in
the EnvisionTEC acquisition that is included in cost of sales.

Gross Loss and Gross Margin

The following table presents gross loss by revenue stream, as well as change in gross loss dollars from the prior period.






                              For the Three
                              Months Ended
                               March 31,            Change in Gross
                           2021          2020            Profit

(Dollars in thousands)     Gross Profit (Loss)          $          %
Products                 $   (176)     $ (2,347)   $      2,171    93 %
Services                     (411)         (472)             61    13 %
Total                    $   (587)     $ (2,819)   $      2,232    79 %




Total gross loss during the three months ended March 31, 2021 and 2020 was $0.6
million and $2.8 million, respectively. The decrease in gross loss of $2.2
million is driven by the EnvisionTEC acquisition, as well as our more diverse
product mix sold during the three months ended March 31, 2021, compared to only
one product shipping during the three months ended March 31, 2020. Negative
gross profit during these periods was the result of higher system costs than
selling price, primarily driven by a combination of small purchase quantities
for systems and consumables from our third-party contract manufacturers,
resulting in higher costs, and the selection of suppliers influenced by
time-to-market considerations instead of cost considerations.

The following table presents gross margin by revenue stream, as well as the change in gross margin from the prior period.






                           For the Three
                           Months Ended       Change in Gross
                             March 31,             Margin
                           2021      2020     Percentage

(Dollars in thousands)      Gross Margin        Points      %
Products                     (2) %    (87) %         0.85   98 %
Services                    (41) %    (68) %         0.27   40 %
Total                        (5) %    (83) %         0.78   94 %




Total gross margin for three months ended March 31, 2021 and 2020 was (5)% and
(83)%, respectively. The increase in total gross margin was primarily due to the
increase in gross margin from our product revenue, which resulted from a lower
product cost for units shipped in the three months ended March 31, 2021 as
compared to three months ended March 31, 2020.

Research and Development



Research and development expenses during the three months ended March 31, 2021
and 2020 were $10.9 million and $12.3 million, respectively, a decrease of $1.4
million, or 11%. The decrease in research and development expenses was primarily
due to a $1.0 million decrease in engineering consulting and prototyping costs
related to the maturation of our product development efforts. Additionally,
compensation costs decreased $0.5 million as a result of a reduction in
headcount due to the COVID-19 pandemic.

Sales and Marketing



Sales and marketing expenses during the three months ended March 31, 2021 and
2020 were $5.4 million and $4.5 million, respectively, an increase of $0.9
million, or 20%. The increase in sales and marketing expenses was primarily due
to increased expense related to EnvisionTEC, partially offset by a reduction in
tradeshow and related travel expenses and marketing headcount during the three
months ended March 31, 2021 due to the COVID-19 pandemic.

                                       35

  Table of Contents

General and Administrative

General and administrative expenses during the three months ended March 31, 2021
and 2020 were $13.8 million and $2.6 million, respectively, an increase of $11.2
million, or 431%. The increase in general and administrative expenses was
primarily due to an increase of $7.5 million of professional fees incurred as a
result of merger and acquisition activity and costs related to operating as a
public company. Additionally, compensation costs increased by $1.5 million,
related to hiring to support public company requirements.

Change in Fair Value of Warrant Liability



Change in fair value of warrant liability during the three months ended March
31, 2021, and 2020, were a $56.6 million loss and $0, respectively. The decrease
in fair value is the result of the remeasurement of the Private Placement
Warrant liability prior to the cashless exercise of the Private Placement
Warrants. The warrant liability increased $56.6 million as a result of the
remeasurement, which resulted in the $56.6 million loss. As of March 31, 2021,
all Private Placement Warrants were exercised and there was no outstanding
warrant liability.

Interest Expense

Interest expense during the three months ended March 31, 2021 and 2020 was $0.1 million in both periods.

Interest and Other Income, Net


Interest and other income, net during the three months ended March 31, 2021 and
2020 and was $0.4 million and $0.6 million, respectively, a decrease of $0.2
million, or 33%. Interest income decreased primarily due to a decrease in cash
available for investment.

Income Taxes

We recorded an income tax benefit of $27.9 million during the three months ended
March 31, 2021 compared to no provision for the three months ended March 31,
2020. The increase was due to the partial release of the valuation allowance
related to the deferred tax liability acquired in the EnvisionTEC acquisition.

We have provided a valuation allowance for all of our deferred tax assets as a
result of our historical net losses in the jurisdictions in which we operate,
except for Germany. We continue to assess our future taxable income by
jurisdiction based on our recent historical operating results, the expected
timing of reversal of temporary differences, various tax planning strategies
that we may be able to enact in future periods, the impact of potential
operating changes on our business and our forecast results from operations in
future periods based on available information at the end of each reporting
period. To the extent that we are able to reach the conclusion that deferred tax
assets are realizable based on any combination of the above factors in a single,
or multiple, taxing jurisdictions, a reversal of the related portion of our
existing valuation allowances may occur.

Non-GAAP Financial Information



In addition to our results determined in accordance with GAAP, we believe the
below non-GAAP financial measures are useful in evaluating our operational
performance. We use this non-GAAP financial information to evaluate our ongoing
operations and for internal planning and forecasting purposes. We believe that
this non-GAAP financial information, when taken collectively, may be helpful to
investors in assessing our operating performance.

The non-GAAP financial information excludes, as applicable, stock-based
compensation expense, amortization of acquired intangible assets included in
cost of sales, acquisition-related and other transactional charges included in
general and administrative expense, and change in fair value of warrant
liability. These items are normally included in the comparable measures
calculated and presented in accordance with GAAP. Our management excludes these
items when evaluating our ongoing performance and/or evaluating earnings
potential, and therefore excludes them when presenting non-GAAP financial
measures. Management uses non-GAAP financial measures to supplement our GAAP
results.

                                       36

  Table of Contents

Stock-based compensation is a non-cash expense relating to stock-based awards
issued to executive officers, employees, and outside directors, consisting of
options and restricted stock units. We exclude this expense because it is a
non-cash expense and we assess our internal operations excluding this expense
and believe it facilitates comparisons to the performance of other companies in
our industry.

Amortization of acquired intangible assets is a non-cash expense that is impacted by the timing and magnitude of our acquisitions. We believe the assessment of our operations excluding these costs is relevant to our assessment of internal operations and to comparisons with the performance of other companies in our industry.


Acquisition-related and other transactional charges included in general and
administrative expenses are direct costs related to potential and completed
acquisitions, including transaction fees, due diligence costs, severance,
professional fees, and integration activities. Other transactional charges
include third-party costs related to structuring unusual transactions. The
occurrence and amount of these costs will vary depending on the timing and size
of acquisitions. We believe excluding acquisition-related costs facilitates the
comparison of our financial results to our historical operating results and to
other companies in our industry.

Change in fair value of warrant liability is a non-cash gain or loss impacted by
the fair value of the Private Placement Warrants. We believe the assessment of
our operations excluding this activity is relevant to our assessment of internal
operations and to comparisons with the performance of other companies in our
industry.

We use the below non-GAAP financial measures, and we believe that they assist
our investors, to make period-to-period comparisons of our operational
performance because they provide a view of our operating results without items
that are not, in our view, indicative of our core operating results. We believe
that these non-GAAP financial measures help illustrate underlying trends in our
business, and we use the measures to establish budgets and operational goals for
managing our business and evaluating our performance. We believe that providing
non-GAAP financial measures also affords investors a view of our operating
results that may be more easily compared to the results of other companies in
our industry that use similar financial measures to supplement their GAAP
results.

                                       37

  Table of Contents

The items excluded from the non-GAAP financial measures often have a material
impact on our financial results and such items often recur. Accordingly, the
non-GAAP financial measures included in this Quarterly Report on Form 10-Q
should be considered in addition to, and not as a substitute for, the comparable
measures prepared in accordance with GAAP. The following tables reconcile each
of these non-GAAP financial measures to its most closely comparable GAAP measure
in our financial statements:


                                                              For the Three Months Ended
                                                                      March 31,
(Dollars in thousands)                                           2021             2020
GAAP gross margin                                           $        (587)     $   (2,819)

Stock-based compensation included in cost of sales                     117             100
Amortization of acquired intangible assets included in
cost of sales                                                        1,091               -
Non-GAAP gross margin                                       $          621     $   (2,719)

GAAP operating loss                                         $     (30,740)     $  (22,278)
Stock-based compensation                                             2,217           1,259
Amortization of acquired intangible assets included in
cost of sales                                                        1,091               -
Amortization of acquired intangibles assets                          1,208             164

Acquisition-related and other transactional charges included in general and administrative expenses

                      4,984               -
Non-GAAP operating loss                                     $     (21,240)     $  (20,855)

GAAP net loss                                               $     (59,108)     $  (21,804)
Stock-based compensation                                             2,217           1,259
Amortization of acquired intangible assets included in
cost of sales                                                        1,091               -
Amortization of acquired intangibles assets                          1,208             164

Acquisition-related and other transactional charges included in general and administrative expenses

                      4,984               -
Change in fair value of warrant liability                           56,576 

             -
Non-GAAP net loss                                           $        6,968     $  (20,381)

We define "EBITDA" as net loss plus net interest income, provision for income taxes, depreciation and amortization expense.

We define "Adjusted EBITDA" as EBITDA adjusted for change in fair value of warrant liability, stock-based compensation expense, warrant expense and transaction costs associated with acquisitions.



We believe that the use of EBITDA and Adjusted EBITDA provides an additional
tool for investors to use in evaluating ongoing operating results and trends
because it eliminates the effect of financing, capital expenditures, and
non-cash expenses such as stock-based compensation and warrants, and provides
investors with a means to compare our financial measures with those of
comparable companies, which may present similar non-GAAP financial measures to
investors. However, you should be aware when evaluating EBITDA and Adjusted
EBITDA that we may incur future expenses similar to those excluded when
calculating these measures. In addition, our presentation of these measures
should not be construed as an inference that our future results will be
unaffected by unusual or non-recurring items. Our computation of these measures,
especially Adjusted EBITDA, may not be comparable to other similarly titled
measures computed by other companies because not all companies calculate these
measures in the same fashion.

Because of these limitations, EBITDA and Adjusted EBITDA should not be
considered in isolation or as a substitute for performance measures calculated
in accordance with GAAP. We compensate for these limitations by relying
primarily on our GAAP results and using EBITDA and Adjusted EBITDA on a
supplemental basis. You should review the reconciliation of net loss to EBITDA
and Adjusted EBITDA below and not rely on any single financial measure to
evaluate our business.

                                       38

  Table of Contents

The following table reconciles net loss to EBITDA and Adjusted EBITDA during the three months ended March 31, 2021 and 2020:




                                                    For the Three Months Ended
                                                            March 31,
(Dollars in thousands)                                 2021             2020

Net loss attributable to common stockholders $ (59,108) $ (21,804) Interest (income) expense, net

                              (42)           

(478)


Income tax benefit                                      (27,920)           

-


Depreciation and amortization                              3,892          

2,321


EBITDA                                                  (83,178)        

(19,961)


Change in fair value of warrant liability                 56,576           

   -
Stock compensation expense                                 2,217           1,259
Warrant expense                                                -             139

Transaction costs associated with acquisitions             4,984           

   -
Adjusted EBITDA                                   $     (19,401)     $  (18,563)

Liquidity and Capital Resources



We have incurred a net loss in each of our annual periods since our inception.
We incurred net losses of $59.1 million and $21.8 million during the three
months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, we had
$572.2 million in cash, cash equivalents, and short-term investments. As noted
in the "Recent Developments" section above, we completed the Business
Combination in December 2020, receiving $534.6 million net cash proceeds as a
result of the transaction. Additionally, during the three months ended March 31,
2021, we received $170.7 million in net cash proceeds from the exercise of
public warrants. We expect both to support our operations and investments in the
near term.

Since inception, we have received cumulative net proceeds from the Business
Combination and the sale of our preferred and common stock of $973.4 million to
fund our operations. As of March 31, 2021, our principal sources of liquidity
were our cash, cash equivalents, and short-term investments of $572.2 million
which are principally invested in money market funds and fixed income
instruments.

In June 2018, we entered into a three-year, $20.0 million term loan, which
provided $10.0 million immediately with the remaining principal balance
available to be drawn in up to three draws of not less than $2.0 million for
12 months from close of the facility. We entered into this loan to fund capital
expenditures associated with our corporate office. Interest is calculated using
the Wall Street Journal Prime rate less 50 basis points, payable monthly in
arrears. If our cash and investments fall below $30.0 million, cash equal to the
total outstanding amount of the debt is required to be placed in a money market
account. In connection with this loan, we are also subject to periodic reporting
requirements, and the lender has a first priority lien on all assets. Repayment
terms include interest only payments for 36 months, with the principal coming
due in June 2021.

In April 2020, we received loan proceeds in the amount of approximately $5.4 million under the Paycheck Protection Program, or the "PPP". The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act, provides for loans to qualifying businesses. We repaid the loan in full on May 13, 2020.



In connection with the acquisition of EnvisionTEC, the Company acquired $1.2
million in PPP loans. Under the terms of the CARES Act, PPP loan recipients can
apply for forgiveness for all or a portion of the loan which is dependent upon
the Company having initially qualified for the loan. Furthermore, the loan is
subject to forgiveness to the extent loan proceeds are used for payroll costs,
certain rents, utilities, and mortgage interest expense. The PPP loan has a
maturity date of April 3, 2022 and an interest rate of 1%. Principal and
interest are payable monthly commencing on a date determined by the lender
following the determination of the amount of the PPP loan to be forgiven or
potentially earlier, as determined under applicable Small Business
Administration rules. The outstanding borrowings may be prepaid by the Company
at any time prior to maturity with no prepayment penalties. As of March 31,
2021, the short-term loan balance is $1.0 million, and the long-term balance is
$0.2 million. Subsequent to March 31, 2021, we were notified that the entire
loan balance has been forgiven.

We believe that our existing capital resources will be sufficient to support our operating plan and cash commitments for at least the next 12 months. As of March 31, 2021, we had $416.4 million in cash and cash equivalents, and $155.8 million in short-term



                                       39

Table of Contents

liquid investments. This liquid asset balance significantly exceeds our current liabilities of $39.4 million as of the same date. If we anticipate that our actual results will differ from our operating plan, we believe we have sufficient capabilities to enact cost savings measures to preserve capital.

We expect net losses to continue in connection with our ongoing activities, particularly as we continue to invest in commercialization and new product development. Additionally, we may engage in future acquisitions which may require additional capital.

Cash Flows



Since inception, we have primarily used proceeds from the Business Combination,
issuances of preferred stock and debt instruments to fund our operations. The
following table sets forth a summary of cash flows for the three months ended
March 31, 2021 and 2020:




                                                               For the Three Months Ended
                                                                       March 31,
(Dollars in thousands)                                            2021              2020
Net cash used in operating activities                        $      (41,129)     $ (22,434)
Net cash used in investing activities                              (182,053)         30,680
Net cash provided by financing activities                            157,195            132

Net change in cash, cash equivalents, and restricted cash $ (65,987) $ 8,378






Operating Activities

Net cash used in operating activities was $41.1 million for the three months
ended March 31, 2021, primarily consisting of $59.1 million of net losses,
adjusted for non-cash items, which primarily included loss on change in fair
value of warrant liability of $56.6 million, depreciation and amortization
expense of $3.9 million and stock-based compensation expense of $2.2 million, as
well as a $17.2 million increase in cash consumed by working capital. The
increase in cash consumed by working capital was primarily driven by an increase
in certain assets including inventory and prepaid expenses and other current
assets, alongside a decrease in certain liabilities including accounts payable,
accrued expenses and other current liabilities, and customer deposits. This
increase in cash consumed by working capital was partially offset by an increase
in certain liabilities customer deposits.

Net cash used in operating activities was $22.4 million for the three months
ended March 31, 2020, primarily consisting of $21.8 million of net losses,
adjusted for certain non-cash items, which primarily included depreciation and
amortization expense of $2.3 million and stock-based compensation expense of
$1.3 million, as well as a $4.1 million increase in cash consumed by working
capital. The increase in cash consumed by working capital was primarily driven
by an increase in certain assets including inventory alongside a decrease in
certain liabilities including accounts payable, accrued expenses and other
current liabilities, and deferred revenue. This increase in cash consumed by
working capital was partially offset by a decrease in certain assets including
accounts receivable and prepaid expenses and other current assets and an
increase in certain liabilities including customer deposits.

The majority of our inventory consists of finished goods. Inventory balances may
fluctuate during cycles of new product launch, commercialization and planned
growth of production and sales of products.

Investing Activities



Net cash used in investing activities was $182.1 million for the three months
ended March 31, 2021, primarily consisting of $137.6 million net cash paid to
acquire EnvisionTEC, and purchases of marketable securities of $92.4 million,
offset by proceeds from sales and maturities of marketable securities of $48.2
million. We purchased $0.3 million of property and equipment.

Net cash used in investing activities was $30.7 million for the three months
ended March 31, 2020, primarily consisting of purchases of marketable securities
of $17.6 million, offset by proceeds from sales and maturities of marketable
securities of $49.3 million, as well as purchases of property and equipment

for
$1.0 million.

                                       40

  Table of Contents

Financing Activities

Net cash provided by financing activities was $157.2 million for the three months ended March 31, 2021, consisting primarily of proceeds from the exercise of public warrants.



Net cash provided by financing activities was $0.1 million for the three months
ended December 31, 2020, consisting of proceeds from the exercise of employee
stock options.

Critical Accounting Policies and Significant Estimates


Other than as described below, there were no material changes in the first three
months of 2021 to the information provided under the heading "Critical
Accounting Policies and Estimates" included in our Annual Report on Form 10-K
for the year ended December 31, 2020.

Business Combinations



We account for business combinations using the acquisition method of accounting,
which requires that the assets acquired and liabilities assumed be recorded at
their respective estimated fair values as of the acquisition date. The excess of
the fair value of the purchase consideration over the fair values of these
identifiable assets and liabilities is recorded as goodwill. While we use our
best estimates and judgments, our estimates are inherently uncertain and subject
to refinement. During the measurement period, which may be up to one year from
the acquisition date, we may record adjustments to the fair value of these
tangible and intangible assets acquired and liabilities assumed, with the
corresponding offset to goodwill. We continue to collect information and
reevaluate these estimates and assumptions quarterly and record any adjustments
to our preliminary estimates to goodwill provided that we are within the
measurement period.

The judgments made in determining the estimated fair value assigned to the
assets acquired, as well as the estimated useful life of each asset, can
materially impact the consolidated statements of operations of the periods
subsequent to the acquisition through depreciation and amortization, and in
certain instances through impairment charges, if the asset becomes impaired in
the future. In determining the estimated fair value for intangible assets, we
typically utilize the income approach, which discounts the projected future net
cash flow using a discount rate deemed appropriate by management that reflects
the risks associated with such projected future cash flow. Significant estimates
and assumptions include revenue growth rates, royalty rates, discount rates, and
tax amortization benefit. Determining the useful life of an intangible asset
also requires judgment, as different types of intangible assets will have
different useful lives and certain assets may even be considered to have
indefinite useful lives.

Off-Balance Sheet Arrangements



We have no off-balance sheet arrangements and do not utilize any "structured
debt," "special purpose" or similar unconsolidated entities for liquidity or
financing purposes.

Recent Accounting Pronouncements

Information regarding recent accounting pronouncements is included in "Note 2. Summary of Significant Accounting Policies" to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

© Edgar Online, source Glimpses